Endre Kiss-Toth

Dr. Endre Kiss-Toth

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Immunity
Verified
Journal Article
Closed access
AMAmanda MacKenzie
Amanda MacKenzie
HWHeather L. Wilson
Heather L. Wilson
EKEndre Kiss-Toth
Endre Kiss-Toth
SDSteven K. Dower
Steven K. Dower
RNR.ALan North
R.ALan North
ASAnnmarie Surprenant
Annmarie Surprenant

29 August 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ABAndrew Bowie
Andrew Bowie
EKEndre Kiss-Toth
Endre Kiss-Toth
JSJulian A. Symons
Julian A. Symons
GSGeoffrey L. Smith
Geoffrey L. Smith
SDSteven K. Dower
Steven K. Dower
Luke O'NeillLuke O'Neill
Luke O'Neill
Poxviruses employ many strategies to evade and neutralize the host immune response. In this study, we have identified two vaccinia virus ORFs, termed A46R and A52R, that share amino acid sequence similarity with the Toll/IL-1 receptor (TIR) domain, a motif that defines the IL-1/Toll-like receptor (TLR) superfamily of receptors, which have a key role in innate immunity and inflammation. When expressed in mammalian cells, the protein products of both ORFs were shown to interfere specifically with IL-1 signal transduction. A46R partially inhibited IL-1-mediated activation of the transcription factor NFκB, and A52R potently blocked both IL-1- and TLR4-mediated NFκB activation. MyD88 is a TIR domain-containing adapter molecule known to have a central role in both IL-1 and TLR4 signaling. A52R mimicked the dominant-negative effect of a truncated version of MyD88 on IL-1, TLR4, and IL-18 signaling but had no effect on MyD88-independent signaling pathways. Therefore, A46R and A52R are likely to represent a mechanism used by vaccinia virus of suppressing TIR domain-dependent intracellular signaling.

1 October 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
EKEndre Kiss-Toth
Endre Kiss-Toth
SBStephanie M. Bagstaff
Stephanie M. Bagstaff
HSHye Y. Sung
Hye Y. Sung
VJVeronika Jozsa
Veronika Jozsa
CDClare Dempsey
Clare Dempsey
SDSteven K. Dower
Steven K. Dower
Control of mitogen-activated protein kinase (MAPK) cascades is central to regulation of many cellular responses. We describe here human tribbles homologues (Htrbs) that control MAPK activity. MAPK kinases interact with Trbs and regulate their steady state levels. Further, Trbs selectively regulate the activation of extracellular signal-regulated kinases, c-Jun NH2-terminal kinases, and p38 MAPK with different relative levels of activity for the three classes of MAPK observed depending on the level of Trb expression. These results suggest that Trbs control both the extent and the specificity of MAPK kinase activation of MAPK.

15 December 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DWD. H. Wyllie
D. H. Wyllie
EKEndre Kiss-Toth
Endre Kiss-Toth
AVA. Visintin
A. Visintin
SSS. C. Smith
S. C. Smith
SBS. Boussouf
S. Boussouf
SDS. K. Dower
S. K. Dower
Members of the Toll-like receptor (TLR) family are components of the mammalian anti-microbial response, signaling with a domain closely related to that of IL-1 receptors. In this report the expression and function of TLR1, a TLR of unknown function, are examined. TLR1 is expressed by monocytes, as demonstrated using a novel mAb. Monocytes also express TLR2. TLR1 transfection of HeLa cells, which express neither TLR1 nor TLR2, was not sufficient to confer responsiveness to several microbial extracts. However, cotransfection of TLR1 and TLR2 resulted in enhanced signaling by HeLa cells to soluble factors released from Neisseria meningitidis relative to the response with either TLR alone. This phenomenon was also seen with high concentrations of some preparations of LPS. The N. meningitidis factors recognized by TLR1/TLR2 were not released by N. meningitidis mutant in the LpxA gene. Although LpxA is required for LPS biosynthesis, because cooperation between TLR1 and TLR2 was not seen with all LPS preparations, the microbial component(s) TLR1/2 recognizes is likely to be a complex of LPS and other molecules or a compound metabolically and chemically related to LPS. The functional IL-1R consists of a heterodimer; this report suggests a similar mechanism for TLR1 and TLR2, for certain agonists. These data further suggest that mammalian responsiveness to some bacterial products may be mediated by combinations of TLRs, suggesting a mechanism for diversifying the repertoire of Toll-mediated responses.

1 February 2007 in Cellular Signalling
Verified
Journal Article
Closed access
ZHZ. Hegedus
Z. Hegedus
ACA. Czibula
A. Czibula
EKEndre Kiss-Toth
Endre Kiss-Toth

10 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
IGIngrid Gomez
Ingrid Gomez
BWBen Ward
Ben Ward
CSCeline Souilhol
Celine Souilhol
CRChiara Recarti
Chiara Recarti
MAMark Ariaans
Mark Ariaans
VRVictoria Ridger
Victoria Ridger
Neutrophils are implicated in the pathogenesis of atherosclerosis but are seldom detected in atherosclerotic plaques. We investigated whether neutrophil-derived microvesicles may influence arterial pathophysiology. Here we report that levels of circulating neutrophil microvesicles are enhanced by exposure to a high fat diet, a known risk factor for atherosclerosis. Neutrophil microvesicles accumulate at disease-prone regions of arteries exposed to disturbed flow patterns, and promote vascular inflammation and atherosclerosis in a murine model. Using cultured endothelial cells exposed to disturbed flow, we demonstrate that neutrophil microvesicles promote inflammatory gene expression by delivering miR-155, enhancing NF-κB activation. Similarly, neutrophil microvesicles increase miR-155 and enhance NF-κB at disease-prone sites of disturbed flow in vivo. Enhancement of atherosclerotic plaque formation and increase in macrophage content by neutrophil microvesicles is dependent on miR-155. We conclude that neutrophils contribute to vascular inflammation and atherogenesis through delivery of microvesicles carrying miR-155 to disease-prone regions.